# Greater Occipital Nerve Block Versus Metoclopramide

> **NCT03269435** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 99 (actual)

## Conditions studied

- Migraine

## Interventions

- **PROCEDURE:** Greater occipital nerve block with bupivacaine
- **DRUG:** Metoclopramide

## Key facts

- **NCT ID:** NCT03269435
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2020-03-21
- **Final completion:** 2020-03-21
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03269435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03269435, "Greater Occipital Nerve Block Versus Metoclopramide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03269435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*